ResearcherMemorial Sloan Kettering Cancer CenterNo recent work listed
Louise M. Fanchon
Matched on ORCID iD 0000-0001-7600-1155; OpenAlex author ID A5006676348. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2020: 1 paper · 2021: none · 2022: 1 paper
Papers 2
- Analysis of capecitabine metabolites in conjunction with digital autoradiography in a murine model of pancreatic cancer suggests extensive drug penetration thr… First author DOI 10.1002/prp2.898↗
- Comparing the intra-tumoral distribution of Gemcitabine, 5-Fluorouracil, and Capecitabine in a murine model of pancreatic ductal adenocarcinoma. Co-author DOI 10.1371/journal.pone.0231745↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Nagavarakishore Pillarsetty · 2 shared papers, 2020–2022 · strength 0.28
- Paper Analysis of capecitabine metabolites in conjunction with digital autoradiography in a murine model of pancreatic cancer… DOI 10.1002/prp2.898↗
- Paper Comparing the intra-tumoral distribution of Gemcitabine, 5-Fluorouracil, and Capecitabine in a murine model of pancreat… DOI 10.1371/journal.pone.0231745↗
- James Russell · 2 shared papers, 2020–2022 · strength 0.28
- Paper Analysis of capecitabine metabolites in conjunction with digital autoradiography in a murine model of pancreatic cancer… DOI 10.1002/prp2.898↗
- Paper Comparing the intra-tumoral distribution of Gemcitabine, 5-Fluorouracil, and Capecitabine in a murine model of pancreat… DOI 10.1371/journal.pone.0231745↗
- John Laurence Humm · 2 shared papers, 2020–2022 · strength 0.28
- Paper Analysis of capecitabine metabolites in conjunction with digital autoradiography in a murine model of pancreatic cancer… DOI 10.1002/prp2.898↗
- Paper Comparing the intra-tumoral distribution of Gemcitabine, 5-Fluorouracil, and Capecitabine in a murine model of pancreat… DOI 10.1371/journal.pone.0231745↗
- Kenneth H. Yu · 1 shared paper, 2020 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.